Research Article| Volume 34, ISSUE 5, P582-586, September 2016

Download started.


Compliance and phototherapy


      When beginning a phototherapy regimen for a patient, consideration of compliance rates is important. Compliance to phototherapy can be affected by several factors, including the grade of discomfort and side effects from therapy, failure of previous therapies, accessibility and convenience to reach the phototherapy center, grade of improvement during phototherapy, patient relief due to light therapy, and rapport with staff. Understanding how these factors can affect patient adherence can allow for phototherapy regimens to be tailored in a manner that optimizes health outcomes and allows for proper patient selection.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • New England Health Institute
        Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease.
        An NEHI Research Brief, 2009 (Available at:
        • Storm A.
        • Anderson S.E.
        • Benfeldt E.
        • et al.
        One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic.
        J Am Acad Dermatol. 2008; 59: 27-33
        • Serup J.
        • Lindbland A.K.
        • Maroti M.
        To follow or not to follow dermatologic treatment—a review of the literature.
        Acta Derm Venereol. 2006; 86: 193-197
        • Kandaswamy S.
        • Akhtar N.
        • Ravindran S.
        • et al.
        Phototherapy in vitiligo: assessing the compliance, response, and patient’s perception about disease and treatment.
        Indian J Dermatol. 2013; 58: 325
        • Kalia S.
        • Toosi B.
        • Bansback N.
        • et al.
        Assessing adherence with phototherapy protocols.
        J Am Acad Dermatol. 2014; 71: 1259-1260
        • Chan S.A.
        • Hussain F.
        • Lawson L.G.
        • et al.
        Factors assessing adherence to psoriasis treatment: comparing biologic treatment to other modalities.
        J Dermatol Treat. 2013; 24: 63-69
        • Yentzer B.A.
        • Yelverton C.B.
        • Pearce D.J.
        • et al.
        Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis.
        J Am Acad Dermatol. 2008; 59: 577-581
        • Finch T.
        • Shin T.N.
        • Roberts L.
        • et al.
        Treatment satisfaction among patients with moderate-to-severe psoriasis.
        J Clin Aesthet Dermatol. 2015; 8: 26-30
        • Evers A.W.
        • Kleinpenning M.M.
        • Smits T.
        • et al.
        Treatment nonadherence and long-term effects of narrowband UV-B therapy in patients with psoriasis.
        Arch Dermatol. 2010; 146: 198-199
        • Davis S.A.
        • Feldman S.R.
        Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials.
        JAMA Dermatol. 2013; 149: 490-491
        • Yentzer B.A.
        • Gustafson C.J.
        • Feldman S.R.
        Explicit and implicit copayments for phototherapy: examining the cost of commuting.
        Dermatol Online J. 2013; 19: 5
        • Schmieder A.
        • Schaarschmidt M.L.
        • Umar N.
        • et al.
        Comorbidities significantly impact patients’ preferences for psoriasis treatments.
        J Am Acad Dermatol. 2012; 67: 363-372
        • Charman C.R.
        • Morris A.D.
        • Williams H.C.
        Topical corticosteroid phobia in patients with atopic eczema.
        Br J Dermatol. 2000; 142: 931-936
        • Matz H.
        Phototherapy for psoriasis: what to choose and how to use: facts and controversies.
        Clin Dermatol. 2010; 28: 73-80
        • Osterberg L.
        • Blaschke T.
        Adherence to medication.
        N Engl J Med. 2005; 353: 487-497
        • Reich K.
        • Mrowietz U.
        • Karakasili E.
        • et al.
        Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).
        Arch Dermatol Res. 2014; 306: 667-676
        • Renzi C.
        • Picardi A.
        • Abeni D.
        • et al.
        Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance.
        Arch Dermatol. 2002; 138: 337-342
        • Practical Dermatology
        How do you optimize compliance and outcomes in phototherapy?.
        Weighing therapeutic options: topical combinations and phototherapy. 2010 (Available from:
        • Tartaglia K.M.
        • Campbell J.
        • Shanluk P.
        • et al.
        A quality project to improve compliance with AAP guidelines for inpatient management of neonatal hyperbilirubinemia.
        Hosp Pediatr. 2013; 3: 251-257
        • Longhurst C.
        • Turner S.
        • Burgos A.E.
        Development of a web-based decision support tool to increase use of neonatal hyperbilirubinemia guidelines.
        Jt Comm J Qual Patient Saf. 2009; 35: 256-262
        • Cameron H.
        • Yule S.
        • Moseley H.
        • et al.
        Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service.
        Br J Dermatol. 2002; 147: 957-965
        • Nolan B.V.
        • Yentzer B.A.
        • Feldman S.R.
        A review of home phototherapy for psoriasis.
        Dermatol Online J. 2010; 16: 1
        • Yelverton C.B.
        • Balkrishnan R.
        • Feldman S.R.
        The utility of a data-logging device for measuring adherence to home phototherapy.
        Photodermatol Photoimmunol Photomed. 2006; 22: 270-272
        • Koek M.B.G.
        • Buskens E.
        • van Weelden H.
        • et al.
        Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).
        BMJ. 2009; 338: b1542
        • Yentzer B.A.
        • Yelverton C.B.
        • Simpson G.L.
        • et al.
        Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
        Dermatol Online J. 2009; 15: 1
        • Vano-Galvan S.
        • Garate M.T.
        • Flesta-Asin B.
        • et al.
        Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis.
        Actas Dermosifiliogr. 2012; 103: 127-137
        • Anderson K.L.
        • Feldman S.R.
        A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles.
        J Am Acad Dermatol. 2015; 72: 868-878